NASDAQ:KYMR

Kymera Therapeutics Stock Predictions

etoro logo Buy KYMR
*Your capital is at risk
$73.21
+1.92 (+2.69%)
At Close: Jun 03, 2026
Currently predicting for Thu, 4 Jun 2026

KYMR Prediction Chart

KYMR Predictions History

Latest community submissions for KYMR.
Predictor Target Session Target Price Result Direction Accuracy Score
Nov 18, 2025 $62.76 -2.10% $64.31 X 97.58% 0
Nov 18, 2025 $63.26 -1.31% $64.31 X 98.37% 0
Nov 18, 2025 Bullish $64.31 X 1
Jun 30, 2025 $44.72 +1.36% $43.64 X 97.53% 0
Jun 30, 2025 Bullish $43.64 X 0
Oct 25, 2024 $48.19 -1.11% $47.99 V 99.58% 5
Oct 25, 2024 $47.87 -1.77% $47.99 V 99.74% 5
Oct 25, 2024 $61.00 +25.10% $47.99 X 72.89% 0
Sep 16, 2022 $28.51 -0.87% $25.91 V 89.97% 1
Sep 16, 2022 $29.92 +4.04% $25.91 X 84.52% 0
Click to get the best stock tips daily for free!
Forecast Desk

Request A 3-Month Forecast

Ask an approved predictor to map the next 66 trading days for KYMR with a full price path, not just a one-day call.
  • Price path
  • Approved predictor
  • 3-month horizon
ABOUT KYMERA THERAPEUTICS INC.
Kymera Therapeutics
Kymera Therapeutics, Inc., a biopharmaceutical company, focuses on discovering and developing novel small molecule therapeutics that selectively degrade disease-causing proteins by harnessing the body's own natural protein degradation system. It engages in developing IRAK4 program, which is in Phase I clinical trial for the treatment of immunology-inflammation diseases, including hidradenitis suppurativa, atopic dermatitis, macrophage activation ...
GOLDEN STAR
Ticker Change Signal Date
RUN
$12.83
18.86% May 06
GLBE
$31.61
5.35% May 05
SAP
$172.39
10.69% May 05
W
WCLD
$27.34
27.18% Apr 29
ADBE
$243.57
7.61% Apr 29

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE